EUVIMEDEUVIMED entdecken
Crossref

Targeting Trop-2 as a Cancer Driver

Emanuela Guerra iD, Marco Trerotola iD, Saverio Alberti iD

Journal of Clinical Oncology · 10.10.2023 · 41 (29) · 4688-4692

DOI: 10.1200/jco.23.01207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.10.2023. Verfasst von Emanuela Guerra und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cancer Pathology, Center for Advanced Studies and Technology (CAST), G. d'Annunzio University of Chieti-Pescara, Chieti, Italy. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Laboratory of Cancer Pathology, Center for Advanced Studies and Technology (CAST), G. d'Annunzio University of Chieti-Pescara, Chieti, Italy.
  • Department of Medical, Oral and Biotechnological Sciences, G. d'Annunzio University of Chieti-Pescara, Chieti, Italy.
  • Unit of Medical Genetics, Department of Biomedical Sciences-BIOMORF, University of Messina, Messina, Italy.

ORCID-Profile: Emanuela Guerra, Marco Trerotola, Saverio Alberti

Zitieren

APA

Guerra, E., Trerotola, M., & Alberti, S. (2023). Targeting Trop-2 as a Cancer Driver. Journal of Clinical Oncology, 41(29), 4688-4692. https://doi.org/10.1200/jco.23.01207

Vancouver

Guerra E, Trerotola M, Alberti S. Targeting Trop-2 as a Cancer Driver. Journal of Clinical Oncology. 2023;41(29):4688-4692. doi:10.1200/jco.23.01207

BibTeX
@article{Guerra2023,
  author = {Guerra, Emanuela and Trerotola, Marco and Alberti, Saverio},
  title = {Targeting Trop-2 as a Cancer Driver},
  journal = {Journal of Clinical Oncology},
  year = {2023},
  volume = {41},
  number = {29},
  pages = {4688--4692},
  doi = {10.1200/jco.23.01207}
}
Kostenlos starten →